摘要
近年来,非结核分枝杆菌(non-tuberculous mycobacteria,NTM)病呈快速增多趋势,已成为威胁人类健康的重要公共卫生问题之一,受到广泛关注。为此,中华医学会结核病学分会组织相关领域专家,在我国2012年《非结核分枝杆菌病诊断与治疗专家共识》的基础上,参考美国胸科协会等2020年发布的《NTM病治疗指南》、英国胸科协会2017年发布的《NTM肺病管理指南》和国内外近年来对NTM病的研究成果与诊治经验,制定了《非结核分枝杆菌病诊断与治疗指南(2020年版)》(简称《指南》),对我国NTM病临床诊疗实践的规范化具有重要指导意义。作者就其主要内容进行解读,供广大同道借鉴和参考,以期更好地理解《指南》,提高临床实践效果。
In recent years,non-tuberculous mycobacteria(NTM)disease is increasing rapidly,which has become one of the important public health problems threatening human health and has been widely concerned.Therefore,based on the Chinese expert consensus on diagnosis and treatment of non-tuberculous mycobacteria disease,the Tuberculosis Branch of the Chinese Medical Association organized experts in related fields to develop the Guidelines for diagnosis and treatment of non-tuberculous mycobacteria disease(2020 edition)by referring to the Treatment of nontuberculous mycobacterial pulmonary disease:an official ATS/ERS/ESCMID/IDSA clinical practice guideline issued in 2020,the British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease(NTM-PD)issued in 2017,as well as the research achievements and diagnosis and treatment experience of NTM disease at home and abroad in recent years.The guidelines has important guiding significance for the standardization of the clinical diagnosis and treatment practice of NTM in China.In order to help the fellow peers to better understand this guideline and improve the clinical practice,the authors interpreted its main contents for reference.
作者
刘盛盛
唐神结
LIU Sheng-sheng;TANG Shen-jie(Multidisciplinary Diagnosis and Treatment Centre for Tuberculosis,Beijing Chest Hospital,Capital Medical University,Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149,China)
出处
《结核与肺部疾病杂志》
2021年第2期108-115,共8页
Journal of Tuberculosis and Lung Disease
基金
北京市临床重点专科项目(202012)。
关键词
分枝杆菌
非典型性
诊断
治疗
指南
评论
Mycobacteria
atypical
Diagnosis
Treatment
Guidebooks
Comment
